Treatment of endometriosis with cyproterone acetate. Preliminary report.
Cyproterone acetate treatment for six months improved dysmenorrhea and reduced endometriosis severity in seven patients, though it caused menstrual disorders and minimal changes in hirsutism.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (10)
- Medical treatments of endometriosis: a review 2022
- Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis 2018
- Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique®) in the treatment of endometriosis symptoms: A prospective open-label comparative study 2018
- Oral and depot progestin therapy for endometriosis: towards a personalized medicine 2017
- Endometriosis 2009
- Medical Management of Endometriosis 2006
- Treatment of symptomatic rectovaginal endometriosis with an estrogen–progestogen combination versus low-dose norethindrone acetate 2005
- Emerging drugs for endometriosis 2004
- Progestogens for endometriosis: forward to the past 2003
- Important effects of cyproterone acetate on endometriosis? 2002
Source provenance
- europepmc
- last seen: 2026-08-16T09:21:09.727480+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:11:08.331550+00:00